Page 36 - focusUnimore_ottobre-novembre2022

Ad Unimore importante finanziamento PNRR sulla

diagnostica e terapie innovative nella medicina di

precisione

Unimore receives major NRRP funding for innovative diagnostics and therapies in precision medi-
cine

Under the coordination of Carlo Bortolotti, Associate Professor of Physical Chemistry, and Massimo Dominici,
Professor of Oncology, our University participated in the NRRP call for Extended Partnerships on Innovative
Diagnostics and Therapies in Precision Medicine. The HEAL ITALIA project, from ‘Health Extended ALliance
for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision Medicine’, for a
duration of 3 years, aims to provide innovative, cost-effective and evidence-based predictive and non-inva-
sive tools. Faster, earlier, more accurate, accessible and cost-effective diagnostic pathways will be available
for monogenic (rare diseases), polygenic (cardiovascular and metabolic) disorders and cancer. Pre-clinical
models and clinical trials for innovative new therapeutic approaches, including cell-based ones, will also be
developed. The University will coordinate a Spoke for devices/materials for precision medicine, with the work
of dozens of researchers addressing the topic of precision medicine from multiple perspectives: metabolic,
hepatological, haematological, cardiological, nephrological, pneumological, dermatological, endocrinologi-
cal and reproductive medicine, surgical, rheumatological and oncological. New technologies relating to
the study of the microbiome, extracellular vesicles, radiomics to bioprinting to robotics applied to precision
surgery as well as cell and gene therapies will also be introduced. All this will make it possible to create a
‘Unimore working group’ on precision medicine, laying the foundations for new diagnostics and therapies in
the medical field with a desirable impact on the local healthcare and biomedical fabric of the area.

on il coordinamento del Prof. Marche, Foggia, Catania, Cagliari, Sapienza, Tor
Carlo Bortolotti, Associato Vergata, Pisa) con il coordinamento dall’Università
di Chimica Fisica, e del Prof. di Palermo, quale Hub del progetto.

Massimo Dominici, Ordi- Il finanziamento complessivo di circa 115
Cnario di Oncologia, il nostro Milioni di Euro consentirà di finanziare ri-
Ateneo ha partecipato al bando PNRR su Parte- cercatori e dottorati di ricerca impegnati in
nariati estesi relativi alla diagnostica e terapie attività di ricerca fondamentale e applicata.
innovative nella medicina di precisione. Il Sono inoltre previsti progetti di supporto alla na-
bando, estremamente competitivo, ha visto l’A- scita e allo sviluppo di start-up da ricerca, attività
teneo primeggiare con altri 25 partner tra i quali di formazione in sinergia tra Università e imprese,
11 atenei (Bicocca, Verona, Bologna, Politecnica con particolare riferimento alle PMI, per ridurre il

36